Pharmacology of polymyxins: new insights into an 'old' class of antibiotics. - Wikidata - awgldk - TriplyDB

Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.

Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.

http://www.wikidata.org/entity/Q34346283

about

Novel formulations for antimicrobial peptides A Molecularly Complete Planar Bacterial Outer Membrane Platform Latarcins: versatile spider venom peptides Interaction of the antimicrobial peptide polymyxin B1 with both membranes of E. coli: a molecular dynamics study New amphiphilic neamine derivatives active against resistant Pseudomonas aeruginosa and their interactions with lipopolysaccharides Probing the penetration of antimicrobial polymyxin lipopeptides into gram-negative bacteria 3-Hydroxyterphenyllin, a natural fungal metabolite, induces apoptosis and S phase arrest in human ovarian carcinoma cells Teaching 'old' polymyxins new tricks: new-generation lipopeptides targeting gram-negative 'superbugs'.A Review of Novel Combinations of Colistin and Lipopeptide or Glycopeptide Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii.Lycopene attenuates colistin-induced nephrotoxicity in mice via activation of the Nrf2/HO-1 pathway.Colistin and polymyxin B: peas in a pod, or chalk and cheese?Significant accumulation of polymyxin in single renal tubular cells: a medicinal chemistry and triple correlative microscopy approach.Imaging the distribution of polymyxins in the kidney Autophagy regulates colistin-induced apoptosis in PC-12 cells.Pro-moieties of antimicrobial peptide prodrugs.Characterization of the colistin (polymyxin E1 and E2) biosynthetic gene cluster.Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance Polymyxin E Induces Rapid Paenibacillus polymyxa Death by Damaging Cell Membrane while Ca2+ Can Protect Cells from Damage.Polymyxin B Nephrotoxicity: From Organ to Cell Damage.Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two 'old' antibiotics-polymyxin B and chloramphenicol.Cellular Uptake and Localization of Polymyxins in Renal Tubular Cells Using Rationally Designed Fluorescent Probes.Searching for new strategies against biofilm infections: Colistin-AMP combinations against Pseudomonas aeruginosa and Staphylococcus aureus single- and double-species biofilms.Human oligopeptide transporter 2 (PEPT2) mediates cellular uptake of polymyxins.Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumannii.Activity and Predicted Nephrotoxicity of Synthetic Antibiotics Based on Polymyxin B.Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii.Transcriptomic Analysis of the Activity of a Novel Polymyxin against Staphylococcus aureus.Antimicrobial Activity and Toxicity of the Major Lipopeptide Components of Polymyxin B and Colistin: Last-line Antibiotics against Multidrug-Resistant Gram-negative Bacteria Cathelicidin Antimicrobial Peptides with Reduced Activation of Toll-Like Receptor Signaling Have Potent Bactericidal Activity against Colistin-Resistant Bacteria Synergistic Nisin-Polymyxin Combinations for the Control of Pseudomonas Biofilm Formation.Comparative pharmacodynamics of four different carbapenems in combination with polymyxin B against carbapenem-resistant Acinetobacter baumannii.An "Unlikely" Pair: The Antimicrobial Synergy of Polymyxin B in Combination with the Cystic Fibrosis Transmembrane Conductance Regulator Drugs KALYDECO and ORKAMBI.A Novel Chemical Biology Approach for Mapping of Polymyxin Lipopeptide Antibody Binding Epitopes Oxidative Stress Induced by Polymyxin E Is Involved in Rapid Killing of Paenibacillus polymyxa.Untargeted metabolomics analysis reveals key pathways responsible for the synergistic killing of colistin and doripenem combination against Acinetobacter baumannii.Colistimethate sodium dry powder for inhalation: a review of its use in the treatment of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.Product information for parenteral colistin varies substantially across Europe.Liposomal antibiotic formulations for targeting the lungs in the treatment of Pseudomonas aeruginosa.Antibacterial mechanisms of polymyxin and bacterial resistance.Therapeutic cyclic lipopeptides mining from microbes: latest strides and hurdles.

P2860

Q26991771-CFA03818-5054-430F-8D0A-8E7B6C7ADAD8 Q27313030-9D0B7D85-BB80-4347-99A2-D9E1864C5236 Q28266394-360CB7D4-5E86-424F-96D2-2459F92D6135 Q28546494-C51C1061-A96C-43BB-8B5F-5BCBF98462EF Q28654498-2D407424-C684-40E5-B98C-9B96AE600586 Q30576597-A51A9E4D-8D14-4ABE-B30B-2F9C6E37C44D Q32181056-43587F5D-E7FC-41F4-9A26-631AA678A1A5 Q33662378-47A6CC29-4B8A-46C5-A828-7393E20C8625 Q34726120-1A0845F4-43F5-4CC7-91B9-FCD659AE1CC2 Q34922961-7D1BC4A4-F3D8-4A08-AEB4-7B0ED0DDF0F6 Q35008357-2BF6D50C-7298-40D1-931E-D94D57011962 Q35054109-E8E2D830-10CB-49CD-95D8-6D0C9886EB34 Q35056878-97BFEF57-2A13-49E0-8B7A-F41B67246FC5 Q35169023-4CBF3134-A50F-4344-A7FB-71B93332D298 Q35543287-F548AD83-EF3F-439C-8F41-EF16E4BE2A1C Q35546948-A8F493DD-8A19-4951-89E3-61A49B3BCBD5 Q35551122-EE242D3E-B3AC-4E5B-97FD-473E5218A14D Q35739828-D5B5E7A4-8A51-40C9-9037-EFBE7FEE9560 Q36105647-3D482294-3EE8-450E-9A61-3741827C5443 Q36255587-2FC2ADE4-FF2B-427E-B451-4D4956D94F1F Q36290642-A13269B0-0B7A-40B2-9D09-80112035AB60 Q36326740-EC9017EE-844B-4245-A509-D2C1D0461FF5 Q36455352-26070D5E-C1BD-45E8-9A6D-192F57C0DDB3 Q36628128-D41E58B4-0848-4A6B-8435-8EA87A2BB383 Q36641728-E19BE821-1913-4668-AF25-B1A7E08BA6E9 Q37014270-F9B3EEB4-CE45-470A-A79E-F2D4209BC4AE Q37132130-CBA156BC-8E60-4502-8C83-0CF623DCE1D0 Q37165591-B27F65F0-2717-4A86-B1EF-F31F42612234 Q37270946-292FC753-BA31-4F24-98D7-E7B7BB49F0B3 Q37366258-80462565-1622-4DBC-95E5-0AD405B97C28 Q37586963-C5D4200D-954A-483B-A980-DAF2B5BEDE23 Q37634327-E6BA262A-AB74-42CC-AAD3-9C9C93C9D960 Q37660423-7933FA9D-608F-4B8F-BAC1-65187AAB3D54 Q37685688-C92E5156-FBFF-44F2-B160-DBB606CC7D0C Q37728145-34A7AD88-BB7E-41C5-BAF6-F92284EB5A1A Q38186636-FFED6936-ED97-4175-8411-E7B95B34528B Q38196299-18BDB7A9-D796-46EA-9EA2-0DA0483ED1FF Q38214155-1AAC68F4-21B0-4B39-A838-640CDCFA6365 Q38348964-3F8467FD-99F8-412F-970C-D8ACC7B240F9 Q38515064-2231DC38-0B4B-446C-98C0-4B87BF92E018

P2860

Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.

http://www.wikidata.org/entity/Q34346283

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.

@ast

Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.

@en

Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.

@nl

type

label

Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.

@ast

Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.

@en

Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.

@nl

prefLabel

Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.

@ast

Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.

@en

Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.

@nl

P1433

Q34346283-355FFD7C-D1AB-4D04-8503-36EA5BCA7A9A

P1476

Q34346283-476B4F1B-238F-40C6-8A2E-6A45708D6E7E

P2093

Q34346283-570069D3-CA1C-46A9-A5DB-8BC1339FB175

Q34346283-5F74FADB-8D01-48ED-8245-955443E20902

Q34346283-C968F656-8395-42DD-BA7F-6E35C35FD0D3

Q34346283-D1E72439-8174-42D8-B783-0E9E00814399

P2860

Q34346283-03AC4368-AFCA-4412-AA55-82FD79A879AC

Q34346283-09E3AEAF-C97D-4FFB-9E4D-D7139D98E250

Q34346283-1165E05B-3D01-4D04-80F1-896762E35979

Q34346283-1977611A-956B-48CE-B4B6-5A7E936EB22B

Q34346283-1BCF0301-BFE7-411C-9345-3B3E004E5BA1

Q34346283-1C03840D-8E9B-4B79-B94E-B97E32A3296B

Q34346283-1E27205F-8BBE-47FA-BA4B-86E618F98003

Q34346283-2158EA86-400A-4703-8C9E-D01A9E545B60

Q34346283-262086F2-141F-4A88-A556-BFF384CC7DE6

Q34346283-298C321F-C443-4389-A3CA-6C1D295FDF68

P304

Q34346283-B5FF1898-7596-432B-89EB-0A2B09C950E6

P31

Q34346283-9B2AB23D-F59F-4ECC-A0E7-239FB8670C56

P356

Q34346283-43F3D68B-FADD-4032-B3AF-597FD33840D8

P433

Q34346283-B9B94C20-E079-4009-95F9-19F8F02E0770

P478

Q34346283-81536BA6-A69A-46AA-9A90-B6A264DAD911

P50

Q34346283-2562B886-0261-46E2-88CE-2EEA31CAC8FC

P577

Q34346283-474EA8E9-6BD7-4843-BC11-86F174219365

P698

Q34346283-3A92BECD-61C3-4567-A51F-ADCC89B5B33D

P921

Q34346283-A7A0F7F2-FD83-4B55-8E6A-AC6130CD1E8C

Q34346283-B8DC97EB-BC5A-4604-81B7-12DC8B853867

P932

Q34346283-BA582F92-EED2-4FEA-AD06-9A508811ACB9

P356

P1433

Future Microbiology

P1476

Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.

@en

P2093

Jian Li

http://www.w3.org/2001/XMLSchema#string

Kade D Roberts

http://www.w3.org/2001/XMLSchema#string

Roger L Nation

http://www.w3.org/2001/XMLSchema#string

Tony Velkov

http://www.w3.org/2001/XMLSchema#string

P2860

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India

Lipid A modification systems in gram-negative bacteria

Lipopolysaccharide endotoxins

The two-component system CprRS senses cationic peptides and triggers adaptive resistance in Pseudomonas aeruginosa independently of ParRS

Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa

Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS

Drugs for bad bugs: confronting the challenges of antibacterial discovery

Molecular basis of bacterial outer membrane permeability revisited

Molecular basis of bacterial outer membrane permeability

P304

711-724

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FMB.13.39

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Philip E. Thompson

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23701329

http://www.w3.org/2001/XMLSchema#string

P921

P932

3852176

http://www.w3.org/2001/XMLSchema#string